Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $35.86 USD
Change Today +1.46 / 4.24%
Volume 603.2K
CEMP On Other Exchanges
As of 3:57 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Peter S. Ringrose Ph.D.

Member of Scientific Advisory Board,Cempra, Inc.
AgeTotal Calculated CompensationThis person is connected to 46 board members in 4 different organizations across 9 different industries.

See Board Relationships


Dr. Peter S. Ringrose, Ph.D., is an Advisor of Excalibur Fund Managers Limited. Dr. Ringrose has been Scientific Advisor of Rigel Pharmaceuticals, Inc. since February 2, 2005. Dr. Ringrose served as the President of Pharmaceutical Research Institute and Chief Scientific Officer of Bristol Myers Squibb Co. from January 2000 to December 2002. Dr. Ringrose served as Scientific Advisor of Bristol-Myers Squibb Co. since January 2, 2003. He joined Bristol-Myers Squibb in January ...

Read Full Background

Corporate Headquarters*

6320 Quadrangle Drive
Chapel Hill, North Carolina 27517

United States

Phone: 919-313-6601
Fax: --

Board Members Memberships*

Director, Member of Nominating and Corporate Governance Committee and Member of Compensation Committee
Non Executive Director
Director, Chairman of Science & Technology Committee and Member of Compensation Committee


University of Cambridge
PhD 1970
University of Cambridge
University of Cambridge

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Exercisable Options24,000
Total Number of Options24,000

Total Compensation*

Total Annual Cash Compensation$80,797
Total Calculated Compensation$666,440
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CEMP:US $35.86 USD +1.46


Clive A. Meanwell M.D., Ph.D.Chairman and Chief Executive Officer
The Medicines Company
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Allergan plc
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
Kenneth C. Frazier Chairman, Chief Executive Officer and President
Merck & Co. Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CEMPRA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at